Clinical Trial Update: Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1/2 study of CICS-1 and SPM-011 using the [18F]FBPA radiotracer, commissioned by CICS, Sumitomo Heavy Industries, and Stella P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracic Cancer

Drugs mentioned

• CICS-1
• SPM-011
• [18F]FBPA

Snippet

Sponsor: Stella Pharma Corporation | Conditions: Thoracic Solid Malignant Tumor | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION